Go to deals
Healthcare | Private Equity

Swissana Clinic AG has been acquired by Hirslanden AG

The private shareholders of Swissana Clinic AG have sold the company to Hirslanden AG for an undisclosed consideration.

Swissana Clinic AG was founded in 1995 and is one of the leading independent hospitals in central Switzerland. It is equipped with three operating rooms, offers 20 in-patient beds with first class comfort and a day hospital with 11 beds.

Hirslanden is the leading group of private hospitals in Switzerland and operates 16 facilities throughout the country. It is owned by Medi-Clinic International, a listed company from South Africa.

Oaklins' team in Switzerland advised the sellers on the preparation of the divestment process and due diligence, the approach and negotiations with potential buyers, and assisted them until closing.

Parties

Talk to the deal team

 Jens  Rutten

Jens Rutten

Partner
Zurich, Switzerland
Oaklins Switzerland

Related deals

Top Systems teams up with Holland Capital to create the premier Dutch battery-based solutions provider
Private Equity | Energy

Top Systems teams up with Holland Capital to create the premier Dutch battery-based solutions provider

Holland Capital, a Netherlands-based private equity firm, has acquired a stake in Top Systems, a leading provider of complete battery-based power solutions, with a unique value-added services proposition.

Learn more
Infotreasury has been sold to Matera
Private Equity | Financial Services | TMT

Infotreasury has been sold to Matera

Matera, a leading banking software company with world-class instant payments and core banking solutions, has acquired Infotreasury.

Learn more
Thrive Freeze Dry has successfully sealed the acquisition deal with Paradiesfrucht GmbH
Private Equity | Food & Beverage

Thrive Freeze Dry has successfully sealed the acquisition deal with Paradiesfrucht GmbH

Paradiesfrucht GmbH, a gobal freeze dryer of fruits, fruit preparations, drops, powders and granulates, has been acquired by Thrive Freeze Dry (Thrive), a portfolio company of Entrepreneurial Equity Partners (e2p) and Mubadala Capital. The transaction is expected to close in 2024, subject to customary closing conditions, including antitrust approval.

Learn more